Skip to content

Preoperative Hemoglobin and Acute Kidney Injury in Emergency Surgery

The Association Between Preoperative Hemoglobin and Acute Kidney Injury in Emergency Surgery: A Prospective Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06857630
Enrollment
420
Registered
2025-03-04
Start date
2025-01-01
Completion date
2027-05-01
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Emergency Surgery, Hemoglobin

Keywords

Acute kidney injury, Emergency surgery, Risk factor, Hemoglobin

Brief summary

Optimization of hemoglobin levels for organ perfusion is essential, especially in critically ill patients. Although anemia is associated with severe organ failure, especially in coronary artery disease, the effects of blood transfusion or various interventions to increase hemoglobin levels on outcomes continue to be debated. The effects of hemoglobin levels in emergency surgery patients on the development of postoperative AKI have been investigated in a small number of studies in the literature, and clear results have not yet been reported. This study was designed to evaluate the effect of hemoglobin levels on the development of AKI after adjustment for known predictive factors.

Detailed description

Acute kidney injury (AKI) is a common complication in patients undergoing major surgery and is associated with both short-term morbidity and mortality and long-term adverse outcomes including the development of Chronic Kidney Failure. Optimization of hemoglobin levels for organ perfusion is essential, especially in critically ill patients. Although anemia is associated with severe organ failure, especially in coronary artery disease, the effects of various interventions such as blood transfusion or increasing hemoglobin levels on outcomes continue to be debated. This prospective observational study was planned to evaluate the effect of hemoglobin levels before emergency surgery on the development of postoperative AKI. Emergency operated patients will be divided into two groups as Group AKI and Group non-AKI according to the development of postoperative renal failure. Postoperative AKI diagnosis and severity will be evaluated according to serum creatinine and/or urine output according to KDIGO (Kidney Disease: Improving Global Outcomes criteria). Demographic characteristics of the patients, preoperative complete blood count, blood biochemistry characteristics, hemodynamic variables, fluid replacement, blood and blood product replacements, surgical characteristics, development and severity of AKI in the postoperative period will be recorded and the effect of hemoglobin level on the development of AKI will be evaluated.

Interventions

OTHERObservational

Postoperative acute kidney injury and hemoglobin level relationship observation

Sponsors

Samsun University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

* Patients undergoing emergency non-cardiac surgery

Exclusion criteria

* Known renal failure * Need for reoperation within 48 hours postoperatively * Exit status within 48 hours postoperatively * Known hematological disease * Known kidney transplantation * Urgent surgery planned due to urinary system related diseases * Patients who did not accept to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Acute renal failure.72 hoursThe effect of hemoglobin level before emergency surgery on the development of postoperative acute renal failure.

Secondary

MeasureTime frameDescription
Hospital days1 monthThe effect of hemoglobin level before emergency surgery on the hospital days

Countries

Turkey (Türkiye)

Contacts

CONTACTözgür kömürcü, 1
zgrkom@gmail.com90 5055273180
CONTACTözgür kömürcü, 2
zgrkom@gmail.com90 505 5273180
STUDY_DIRECTORözgür kömürcü, 1

Samsun University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026